(来源:动脉新医药)诺和诺德迎来多事之秋。2025年7月29日,公司宣布任命现任国际业务负责人Maziar Mike Doustdar为新任总裁兼首席执行官,该任命将于8月7日正式生效。而就在两个多月前,时任CEO Lars Fruergaard Jorgensen在与董事会“达成一致”后宣布辞职,原因是“近期市场挑战”以及股价大幅下跌所带来的压力。这一变动引发外界对诺和诺德领导层与未来战略走向的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.